November 25, 2016

TorBUG welcomes Arfon Smith from GitHub on Wednesday, November 30

Torbug - Lecture illustration

The Toronto Bioinformatics User Group (TorBUG) continues on Wednesday, November 30 with another session of leading-edge bioinformatics topics and speakers. TorBUG sessions encourage learning, sharing and networking with colleagues in bioinformatics. All those who are interested are welcome to attend.

Continue reading – TorBUG welcomes Arfon Smith from GitHub on Wednesday, November 30

November 23, 2016

OICR and OMPRN celebrate International Pathology Day with educational events

A technician works in OICR pathology lab

On November 16 OICR and the Ontario Molecular Pathology Research Network (OMPRN) joined other organizations around the world celebrating International Pathology Day.

Continue reading – OICR and OMPRN celebrate International Pathology Day with educational events

November 21, 2016

New research highlights the importance of family physicians in the cancer system

Dr. Eva Grunfeld

Family physicians are often a patient’s first point of contact in the healthcare system. For those patients with cancer, their family physician plays an important role in their care not just at their time of diagnosis, but also throughout their treatment and for the rest of their lives.

Continue reading – New research highlights the importance of family physicians in the cancer system

November 18, 2016

OICR participates in the fastest, long-distance academic big data transfer in Canada

A picture from OICR's Data Center

OICR was part of a group of organizations to achieve history when they helped reach an important milestone in Canadian computing. As part of the ORION network, OICR participated in an exercise to perform the fastest, long-distance big data transfer between academic institutions in Canada.

Continue reading – OICR participates in the fastest, long-distance academic big data transfer in Canada

November 16, 2016

International Pathology Day 2016

A pathology researcher looks at a slide.

Today is International Pathology Day. Around the world and here in Ontario events will be held to raise awareness of the field and its contributions to modern medicine. The work of the Transformative Pathology Program, coupled with the launch of the Ontario Molecular Pathology Research Network (OMPRN), has made for a very successful year thus far for OICR’s efforts in pathology research. Here are some of the highlights. Continue reading – International Pathology Day 2016

November 9, 2016

The next generation: Tamara Jamaspishvili

Tamara Jamaspishvili

Men newly diagnosed with prostate cancer face a difficult dilemma: either wait and see how the growth develops and whether it is aggressive, or treat it fully right away and risk the many long-term side effects of treatment. Dr. Tamara Jamaspishvili is a young researcher at Queen’s University in Kingston who is working to change that.

Continue reading – The next generation: Tamara Jamaspishvili

November 4, 2016

Beyond the crime scene: You don’t have to be dead to need a pathologist

Cafe Scientifique banner

Dr. John Bartlett, from the Ontario Institute for Cancer Research, and Dr. Michelle Downes, from Sunnybrook Health Science Centre, will take you into a world of pathology beyond crime scene investigation and into puzzles more complex than an escape room. They will talk about the future of pathology and how this is changing the face of medicine and why a pathologist is considered ‘the doctor’s doctor’.

The Duke of York Pub – November 16, 6-8 p.m.
39 Prince Arthur Avenue, Toronto
near St. George subway station

Register at Eventbrite >

November 2, 2016

FACIT start-up Turnstone Biologics closes USD $41M financing

OrbiMed, Versant-led round continues commercialization success for Turnstone’s cancer therapies

John Bell and contributorsTORONTO, Nov. 2, 2016 /CNW/ – Turnstone Biologics Inc. (“Turnstone”), an Ontario-based developer of novel oncolytic viral immunotherapies, announced the closing of a USD $41.4 million Series B financing led by OrbiMed Advisors LLC (“OrbiMed”) and Versant Ventures (“Versant”), which led Turnstone’s Series A round in October 2015. New investor F-Prime Capital Partners (“F-Prime”) and existing founding investor FACIT also participated. Proceeds from the financing will support an ongoing Phase I/II clinical trial in patients with advanced or metastatic solid tumours as well as accelerate and expand Turnstone’s pipeline, funding the development of three additional programs into the clinic. In connection with the financing Orbimed’s Rishi Gupta, JD and F-Prime’s Ben Auspitz will join Turnstone’s board of directors alongside Versant’s Brad Bolzon, PhD and Jerel Davis, PhD as well as FACIT’s Jeff Courtney.

Continue reading – FACIT start-up Turnstone Biologics closes USD $41M financing

November 1, 2016

From our Annual Report: Improving screening for patients with brain cancer

Lead Researcher

Evaluating new therapies for cancer through clinical trials is one of the most important steps in moving novel drugs from the lab to clinical use. Recently Dr. Michael Taylor and his collaborators discovered a way to improve clinical trials for testing new therapies for medulloblastoma, a common form of brain cancer in children. The study was conducted with OICR’s support.

Continue reading – From our Annual Report: Improving screening for patients with brain cancer

October 28, 2016

Pathology Matters: One attendee’s reflections on OMPRN’s first gathering of Ontario pathologists

OMPRN Logo

Dr. Matt Cecchini was one of many pathologists and researchers, including 21 trainees, to attend the inaugural Pathology Matters meeting hosted by the Ontario Molecular Pathology Research Network (OMPRN). In this post he covers what he learned at the meeting, where the field is going and how that impacts his training and research.

Continue reading – Pathology Matters: One attendee’s reflections on OMPRN’s first gathering of Ontario pathologists

October 27, 2016

OICR’s Transformative Pathology Program contributes to recent PanCuRx findings

Ilinca Lungu, a Research Technician in OICR’s Transformative Pathology Program, talks about her group’s contributions to recent findings from the PanCuRx Translational Research Initiative.

Access to the Transformative Pathology Program’s resources and expertise is available to the research community through Diagnostic Development in OICR’s Collaborative Research Resources Directory. For more information about how you can access these services, visit oicr.on.ca/collaborative-research-resources.

October 26, 2016

TorBUG continues tonight with speaker Dr. Laura Hug from the University of Waterloo

Torbug - Lecture illustration

The Toronto Bioinformatics User Group (TorBUG) continues this evening with another session of leading-edge bioinformatics topics and speakers. TorBUG sessions encourage learning, sharing and networking with colleagues in bioinformatics. Anyone who is interested is welcome to attend.

Continue reading – TorBUG continues tonight with speaker Dr. Laura Hug from the University of Waterloo